Resource Library
We’ve compiled a useful collection of resources to learn more about Medrio and various aspects of managing your clinical trial in today’s complex and evolving environment.
Webinar
Moving Beyond Tech Adoption: The Future of Clinical Trial Technology
Join the insightful webinar on the evolution of clinical technology, growing complexity of clinical research and uncover the current challenges and gaps in eClinical tech. Our esteemed speakers, including Medrio's CEO Nicole Latimer, will share their expertise and discuss the future of trials.
eBook
DCT
Fully Remote, Hybrid, or Flexible Hybrid Decentralized Trials
CROs and sponsors must consider multiple factors when deciding between a fully remote, hybrid or flexible hybrid approach for their clinical trial. Read up on the key considerations here!
White Paper
eCOA / ePRO
Utilization of Patient-Reported Outcomes for Medical Device Trials
Medical device sponsors are diversifying study formats, using ePRO tools like apps and web-based solutions. A survey by Medrio and studioID shows that over 90% find ePRO valuable for device trials.
eBook
RTSM
RTSM Readiness Guide
Your RTSM sits at the intersection of your master protocol and data management processes. Being prepared to answer vendor questions on these topics can speed up study build timelines and ensure that your RTSM technology is optimized to support your success.
Webinar
CDMS / EDC•eCOA / ePRO•eConsent
From Discovery to Pivotal Trials: How Freenome’s Partnership with Medrio Enabled Large-Scale Clinical Trials for Early Cancer Detection
Join Freenome's Yontao Lu, Ph.D., and Aijing Gao, along with Medrio's Melissa Newara, as they discuss best practices and share case studies on how to achieve scale without compromising patient needs.
Blog
Importance of Quality Data in Meeting Increasing FDA Regulatory Scrutiny
May 17, 2023
Partnering with a reliable EDC vendor to ensure your clinical trial data meets high standards of accuracy and integrity is essential for passing FDA scrutiny. Risk-based approaches and improved monitoring workflows can help researchers stay ahead of the curve in navigating any potential challenges posed by the FDA, reducing the risk of warnings, rejections or costly additional research.